Hollenberg, Rebecca K <br/><br/>
Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  06 2020 
 - 1404-1412 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2019.1695459  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Viral<br/>Female<br/>Human papillomavirus 16<br/>Human papillomavirus 18<br/>Humans<br/>Leukocytes, Mononuclear<br/>Male<br/>Papillomavirus Infections--prevention & control<br/>Papillomavirus Vaccines<br/>Vaccination<br/>Vaccines, DNA<br/>Young Adult